Armata Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Armata Pharmaceuticals, Inc. (NYSE American: ARMP) on April 2, 2025. The filing announces the scheduling of the Company's 2025 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
There are no material financial changes reported in this filing. The primary event is the establishment of the date and logistics for the upcoming Annual Meeting.
Guidance, Outlook, and Management Commentary
Management has set the following key dates and details for the 2025 Annual Meeting:
- Meeting Date: June 12, 2025
- Time: 8:30 a.m. (Pacific Time)
- Location: 5005 McConnell Avenue, Los Angeles, California 90066 (subject to change as noted in the proxy statement)
- Record Date: Stockholders of record as of the close of business on April 17, 2025, are entitled to vote.
- Proposal Deadline: The deadline for stockholder proposals and director nominations under the Advance Notice Bylaws is 5:00 p.m. (Eastern Time) on April 13, 2025.
Investor Verification Checklist
- Verify the final meeting location and time in the upcoming proxy statement, as the Board reserves the right to change these details.
- Confirm the record date of April 17, 2025, to ensure eligibility to vote.
- Note the April 13, 2025, deadline for submitting stockholder proposals or director nominations.
- Review the Company's Amended and Restated Bylaws for specific compliance requirements regarding advance notice provisions.